)
Visual
test
Rafael
Rafael (RFL) investor relations material
Rafael Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary11 Dec, 2025
Executive summary
Focused on biotechnology with lead candidate Trappsol® Cyclo™ in Phase 3 trials for Niemann-Pick Disease Type C1, following a positive DMC review at 48 weeks; diversified interests in clinical and early-stage pharma and medical device companies.
Completed the acquisition of Cyclo Therapeutics in March 2025, consolidating its results and assets, which led to increased expenses and operational changes.
Real estate holdings now limited to a single commercial property in Jerusalem, Israel.
Financial highlights
Total revenue for the quarter ended October 31, 2025, was $0.24 million, up from $0.13 million year-over-year, driven by product and rental income.
Net loss attributable to shareholders was $9.8 million ($0.19 per share), compared to $9.2 million ($0.37 per share) in the prior year quarter.
Research and development expenses rose to $7.5 million from $1.3 million year-over-year, mainly due to the Cyclo acquisition.
Cash and cash equivalents stood at $45.5 million as of October 31, 2025, down from $52.8 million at July 31, 2025.
Total assets were $105.4 million, with total equity of $89.2 million as of quarter-end.
Outlook and guidance
Cash reserves are expected to be sufficient to meet obligations for at least the next 12 months.
Strategic focus remains on advancing Trappsol® Cyclo™ to regulatory approval and market, while evaluating other holdings for resource allocation.
Management remains optimistic about the clinical progress and potential of Trappsol® Cyclo™.
Forward-looking statements highlight ongoing evaluation of clinical data and pipeline potential, with risks noted.
What's next for Trappsol® Cyclo™ Phase 3 study?
Project cash runway based on Q1 burn rate
Clarify Cyclo investment unrealized loss
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- TW
Record revenue, strong earnings, and digital asset expansion drive robust results. - WEC
Adjusted EPS up 8% to $5.27; 2026 guidance and dividend growth reaffirmed. - VCTR
Q1 saw higher revenue, Amundi deal closed, and dividend raised to $0.49 per share. - MINDACORP
Record revenue and profit growth, margin expansion, and strong outlook amid regulatory changes. - SLQT
Q2 FY2026 revenue up 12% YoY, net income $69.3M, guidance revised for partner headwinds. - NATH
Revenue up, profits down; merger at $102/share and multiple dividends announced. - GOOS
Double-digit revenue growth driven by US and China, but margins pressured by higher SG&A. - VCTRQ4 revenue up 61% YoY, $317B AUM, 52.8% EBITDA margin, and strong global expansion.
- 500570
JLR's cyber incident drove a 25.8% revenue drop, but domestic PV business surged 24% YoY. - VCTRAUM hit $301.6B, adjusted EBITDA up 53%, and buyback authorization rose to $500M.
Next Rafael earnings date
Q2 202613 Mar, 2026
Rafael
Next Rafael earnings date
Q2 202613 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Rafael Holdings Inc operates as a holding company with interests in pharmaceutical development and commercial real estate. The company’s healthcare focus involves supporting novel therapeutics, while its real estate operations include ownership and management of commercial properties. Rafael Holdings serves the healthcare and real estate sectors. The company is headquartered in Newark, New Jersey, and its shares are listed on the NYSE American.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage